Clinical Topics & News

Successful Treatment of Recalcitrant Palmoplantar Psoriasis With Etanercept

Cutis. 2003 November;72(5):396-398
By
Weinberg JM
Author and Disclosure Information

Palmoplantar psoriasis is a disabling condition characterized by recurrent crops of sterile pustules with associated erythema, fissuring, and scaling. Genetic and environmental factors have been implicated in its etiology. Topical treatments are frequently ineffective. Other treatment options include systemic retinoids, psoralen-UVA (PUVA), and a combination of both. We report a case of successful treatment of recalcitrant palmoplantar psoriasis with etanercept in a 59-year-old woman unresponsive to other treatment modalities.
PDF Download

 

Recommended Reading

Tipping the Scales: Biologic Therapy 2002 [editorial]
MDedge Dermatology
A Case of Bullous Pemphigoid Limited to Psoriatic Plaques
MDedge Dermatology
The FDA Guidelines for the Treatment of Psoriasis Using Cyclosporine A: Are They Adequate?
MDedge Dermatology
Patients With Psoriasis Prefer Solution and Foam Vehicles: A Quantitative Assessment of Vehicle Preference
MDedge Dermatology
Trachyonychia: A Case Report and Review of Manifestations, Associations, and Treatments
MDedge Dermatology
Biologic Therapy for Psoriasis: The Tumor Necrosis Factor Inhibitors—Infliximab and Etanercept
MDedge Dermatology
Biologic Therapy for Psoriasis: The T-Cell–Targeted Therapies—Efalizumab and Alefacept
MDedge Dermatology
Stress in a Case of SAPHO Syndrome
MDedge Dermatology
Epidemiology of Skin Diseases in People of Color
MDedge Dermatology
Picking Apart the Picker: A Clinician's Guide for Management of the Patient Presenting With Excoriations
MDedge Dermatology